Trophos
Marseille
About Trophos
Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology and cardiology. Trophos is a fully integrated clinical stage company with a pipeline of original molecules in development for the motoneuron diseases amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and spinal muscular atrophy (SMA), chemotherapy-induced peripheral neuropathy, cardiac ischemia-reperfusion injury and other neurological conditions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $11.6M
- Funding stage: M&A
- Last round: Series C (Sep 2007)
- Website: trophos.com
- Phone: +330491828282
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/trophos-3017958 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.